• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR INC. TREK; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR INC. TREK; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 1012278-30
Medical Device Problem Codes Difficult to Remove (1528); Material Separation (1562); Improper or Incorrect Procedure or Method (2017)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/17/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Event or Problem Description
It was reported that the procedure was to treat a lesion the right coronary artery (rca).The 4.0x30mm trek rx balloon dilatation catheter (bdc) was inflated without issues and deflated for removal.However, the distal portion broke off when it had resistance with the guide catheter and slight force was applied but separated portion was noted to be in the guide wire so the guide wire was simply removed.The procedure was completed at this time.There was no adverse patient effect and there was no clinically significant delay in the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
Visual analysis was performed on the returned device.The reported separation was confirmed.The reported difficulty removing the device from the guiding catheter could not be replicated in a testing environment due to the condition of the returned device.Production record and corrective and preventive actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a review of the complaint history identified no other similar complaints from this lot.It was reported that slight extra force was applied against the reported resistance during removal and the shaft separated.It should be noted that the coronary dilatation catheters (cdc), trek rx and mini trek rx, global, instruction for use (ifu) states: if resistance is felt, determine the cause before proceeding.Continuing to advance or retract the catheter while under resistance may result in damage to the vessels and / or damage / separation of the catheter.In this case, it is likely that the combination of the reported difficulty removing the device and the violation of the ifu contributed to the reported separation.Based on the reported information and results of the complaint investigation there is no indication the reported difficulty removing the device from the guiding catheter is related to a potential product quality issue.Possible factors that can contribute to difficult to remove/resistance with the guiding catheter post-inflation include, but are not limited to, loose balloon folds, guiding catheter lumen obstructions, kinks, bends or procedural technique.Furthermore, the reported separation appears to be related to user error/operational context as difficulty was reported during the attempts to remove the device, it is likely that since the account reported using slight force, the shaft ultimately separated.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.Additional information: d4 - model # added h6 - medical device problem code 2017: excessive force corrections: d1 - brand name updated d2a - common device name updated d3 - name updated d3 - address, city, postal code updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TREK
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
ABBOTT VASCULAR INC.
3200 lakeside drive
santa clara CA 95054 2807
Manufacturer (Section G)
ABBOTT VASCULAR COSTA RICA, REG # 3009564766
52 calle 3 b31 coyol free zone
el coyol alajuela
CS  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key19533883
Report Number2024168-2024-07144
Device Sequence Number20708317
Product Code LOX
UDI-Device Identifier08717648138744
UDI-Public(01)08717648138744(17)251031(10)21128G1
Combination Product (Y/N)N
Initial Reporter StateWI
Initial Reporter CountryUS
PMA/510(K) Number
K103110
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/31/2025
Device Model Number1012278-30
Device Catalogue Number1012278-30
Device Lot Number21128G1
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/31/2024
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 05/21/2024
Supplement Date Received by Manufacturer07/15/2024
Initial Report FDA Received Date06/13/2024
Supplement Report FDA Received Date07/26/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/28/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age74 YR
Patient SexMale
Patient Weight106 KG
-
-